Research programme: HER2 targeted radioimmunotherapies - Tagworks Pharmaceuticals
Alternative Names: RIT: trastuzumab-TCO-DOTALatest Information Update: 26 Jul 2023
At a glance
- Originator Tagworks Pharmaceuticals
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Breast cancer; Gastric cancer
Most Recent Events
- 26 Jul 2023 Early research in Breast cancer in Netherlands (Parenteral), prior to July 2023 (Tagworks Pharmaceuticals, July 2023)
- 26 Jul 2023 Early research in Gastric cancer in Netherlands (Parenteral), prior to July 2023 (Tagworks Pharmaceuticals, July 2023)